Remission of TP53-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33).

  • Guenther Koehne
  • , Muhammad U Mushtaq
  • , Lori S Muffly
  • , Manuel Menes
  • , Jacques Azzi
  • , Lea Bernard
  • , Brenda Cooper
  • , Vanessa Kennedy
  • , Divya Koura
  • , Joseph Maakaron
  • , John Magenau
  • , Brian McClune
  • , Sagar S Patel
  • , Joseph C Rimando
  • , Nirali N Shah
  • , Hyung C Suh
  • , Roni Tamari
  • , Sanjana Thosar
  • , Giacomo Canesin
  • , Sharon L Hyzy
  • Melissa M Lee-Sundlov, Darren A Stanizzi, Diana Hummel, Michelle I Lin, Glen D Raffel, Jennifer S Whangbo, John F DiPersio

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e2500556
JournalJCO precision oncology
Volume9
DOIs
StatePublished - Oct 2025

Cite this